Orinda, California, United States
I’m Dr. Jose Bolanos, MD—Stanford-trained OB/GYN turned cybersecurity innovator. After 25 years in private practice delivering babies and advancing women’s health, I transitioned into digital identity and cybersecurity to solve one of the most pressing challenges of our time: securing digital access with true user verification. As the Founder of Nimbus-T Global, Inc., I developed and patented Nimbus-Key ID, a mobile-first, password-less authentication system using biometric, AI, and KYC technologies. Our platform, DE-MFA®, is designed to protect enterprise systems, healthcare networks, and financial institutions from phishing, credential theft, and identity fraud. I’m passionate about bridging the gap between healthcare and cybersecurity, and I actively contribute to standards development through X9.org. Let’s connect if you’re building the future of secure digital identity.
Our patented Nimbus-Key ID solution provides a more advanced identity and authentication system for enterprise systems to protect employee logins.
Website creation for healthcare industry. Wordpress websites with Nimbus-Key ID secure logins.
Designed and implemented global strategies for iden;ty management, pa;ent safety, and mul;factor authen;ca;on systems. Collaborated with healthcare providers to develop integrated digital health strategies that enhance pa;ent safety, clinical efficiency, and popula;on health outcomes. Spearheaded opera;onal improvements to op;mize pa;ent access to secure health informa;on and services. Member of X9.org, the cybersecurity team to banking in Washington DC.
Thanks for joining our Venture-Med network. We are a angel investment group that focuses on early stage healthcare startup companies. We aim to empower our physician community with the experience to assess companies, teams, intellectual property (IP), experience, and funding requirements to reach milestones. With each milestone such as CE mark or FDA approval the valuation of the company and your investment increases significantly. We focus on medical device (510k FDA) and healthcare IT companies. We look to invest in novel companies and after proper due diligence, we are looking for a 3-5X return in 3 years.